Despite tremendous efforts and ongoing research, until recently there was no specific therapy for diabetic nephropathy (DN) or other chronic progressive kidney diseases (CKD) besides angiotensin-converting enzyme (ACE) inhibition (Joannidis and Hoste, 2018; Kovesdy, 2022). This evidence concerns the gene ACE and diabetic kidney disease.